Journal of Antimicrobial Chemotherapy (2002) 50, 111-114
© 2002 The British Society for Antimicrobial Chemotherapy
2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ
Drug Discovery Division, Southern Research Institute, 2000 Ninth Avenue South, Birmingham, AL 35205, USA
Received 1 October 2001; returned 3 January 2002; revised 1 March 2002; accepted 2 April 2002
Compounds originally designed as putative tubulin inhibitors were tested as antitubercular agents for inhibition of the Mycobacterium tuberculosis analogue of tubulin, FtsZ. Initial screening of 200 2-alkoxycarbonylpyridines found several that inhibited M. tuberculosis growth. Two compounds, SRI-3072 and SRI-7614, inhibited FtsZ polymerization and were equipotent against susceptible and single-drug-resistant strains of M. tuberculosis. In addition, SRI-3072 reduced the growth of M. tuberculosis in mouse bone marrow macrophages. Our results suggest that these types of compound might be developed into antitubercular drugs effective against the current multidrug-resistant strains of M. tuberculosis.
* Corresponding author. Tel: +1-205-581-2344; Fax: +1-205-581-2877; E-mail: white{at}sri.org
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Villar, E. Vicente, B. Solano, S. Perez-Silanes, I. Aldana, J. A. Maddry, A. J. Lenaerts, S. G. Franzblau, S.-H. Cho, A. Monge, et al. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide J. Antimicrob. Chemother., September 1, 2008; 62(3): 547 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vicente, R. Villar, A. Burguete, B. Solano, S. Perez-Silanes, I. Aldana, J. A. Maddry, A. J. Lenaerts, S. G. Franzblau, S.-h. Cho, et al. Efficacy of Quinoxaline-2-Carboxylate 1,4-Di-N-Oxide Derivatives in Experimental Tuberculosis Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3321 - 3326. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Raghunand and W. R. Bishai Mycobacterium smegmatis whmD and its homologue Mycobacterium tuberculosis whiB2 are functionally equivalent. Microbiology, September 1, 2006; 152(Pt 9): 2735 - 2747. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chauhan, M. V. V. S. Madiraju, M. Fol, H. Lofton, E. Maloney, R. Reynolds, and M. Rajagopalan Mycobacterium tuberculosis Cells Growing in Macrophages Are Filamentous and Deficient in FtsZ Rings. J. Bacteriol., March 1, 2006; 188(5): 1856 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Stokes, J. Sievers, S. Barker, J. M. Bennett, D. R. Brown, I. Collins, V. M. Errington, D. Foulger, M. Hall, R. Halsey, et al. Novel Inhibitors of Bacterial Cytokinesis Identified by a Cell-based Antibiotic Screening Assay J. Biol. Chem., December 2, 2005; 280(48): 39709 - 39715. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ballell, R. A. Field, K. Duncan, and R. J. Young New Small-Molecule Synthetic Antimycobacterials Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2153 - 2163. [Full Text] [PDF] |
||||
![]() |
D. N. Margalit, L. Romberg, R. B. Mets, A. M. Hebert, T. J. Mitchison, M. W. Kirschner, and D. RayChaudhuri Targeting cell division: Small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality PNAS, August 10, 2004; 101(32): 11821 - 11826. [Abstract] [Full Text] [PDF] |
||||





